Sanofi-aventis completes merger in Bangladesh

Sanofi-aventis Bangladesh Ltd is the new entity that has been formed following the amalgamation of three leading pharmaceutical companies -- Aventis Ltd, Fisons (Bangladesh) Ltd and Hoechst Marion Roussel Ltd, says a press release.
The legal integration process has taken few years after the global merger between sanofi-synthalebo and Aventis in September 2004 and finally the existing three legal entities have amalgamated as sanofi-aventis Bangladesh on December 11, 2007.
The name of the newly amalgamated company has been registered with the Registrar of Joint Stock Companies and Firms on January 31, 2008.
Sanofi-aventis, a leading pharmaceutical group that is present in more than 100 countries with around 11,000 scientists and more than 100,000 employees discovers, develops and distributes therapeutic solutions.
Sanofi-aventis Bangladesh contributed a total of Tk 28.4 crore to the national exchequer in the form of tax, VAT, custom duties, etc. in 2007. Bangladesh government holds 45 percent shares in the company.